Novus Biologicals™ UBE2N/Ubc13 Antibody Blocking Peptide

Catalog No.	Quantity
NBP176593E	0.05 mg

Catalog No. NBP176593E Supplier Novus Biologicals™ Supplier No. NBP176593PEP

Description

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

A blocking peptide containing 15 amino acids near the carboxy terminus of human UBC13. Source: Synthetic (Accession #: AAP35519) The UBE2N/Ubc13 Blocking Peptide has been validated for the following applications: Antibody Competition.

Specifications

• Gene ID (Entrez): 7334
• Species: Human
• Content And Storage: Store at -20 C. Avoid freeze-thaw cycles.
• Formulation: PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
• For Use With (Application): This Peptide is Useful as a Blocking Peptide for NBP1-76593. For Further Blocking Peptide Related Protocol, Click Here .
• Gene Alias: bendless-like ubiquitin conjugating enzyme, Bendless-like ubiquitin-conjugating enzyme, BLU, EC 6.3.2.19, MGC131857, MGC8489, UBC13, UbcH-ben, Ubiquitin carrier protein N, ubiquitin-conjugating enzyme E2 N, ubiquitin-conjugating enzyme E2N (homologous to yeast UBC13), ubiquitin-conjugating enzyme E2N (UBC13 homolog, yeast), Ubiquitin-protein ligase N, yeast UBC13 homolog
• Gene Symbol: UBE2N
• Product Type: UBE2N/Ubc13
• Quantity: 0.05 mg
• Regulatory Status: RUO - research use only
• Source: Synthetic
• Termination: 15 amino acids near the carboxy terminus of human UBC13